CD133 was shown to be co-expressed with CD44, the receptor for the glycosaminoglycan hyaluronate [51], in GBM neurospheres [52], and inhibition of CD44 affects GBM progression in mice [53]. The gene discussed is CD44; the disease is glioblastoma.